SELLAS Life Sciences Group Inc (SLS) Analysis & Opinions from Experts

SELLAS Life Sciences Group Inc (NASDAQ: SLS) is -56.78% lower on its value in year-to-date trading and has touched a low of $0.81 and a high of $4.13 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SLS stock was last observed hovering at around $1.15 in the last trading session, with the day’s loss setting it -0.13%.

Currently trading at $1.02, the stock is -5.95% and -0.81% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.3 million and changing -11.30% at the moment leaves the stock -28.20% off its SMA200. SLS registered -55.26% loss for a year compared to 6-month loss of -36.25%. The firm has a 50-day simple moving average (SMA 50) of $20.84 and a 200-day simple moving average (SMA200) of -$0.75.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The stock witnessed a 0.99% gain in the last 1 month and extending the period to 3 months gives it a -33.33%, and is -11.30% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.91% over the week and 11.94% over the month.

SELLAS Life Sciences Group Inc (SLS) has around 17 employees, a market worth around $32.70M and $0.00M in sales. Distance from 52-week low is 26.10% and -75.30% from its 52-week high.

SELLAS Life Sciences Group Inc (SLS) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for SELLAS Life Sciences Group Inc (SLS) is a “Buy”. 4 analysts offering their recommendations for the stock have an average rating of 1.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

SELLAS Life Sciences Group Inc is expected to release its quarterly report on 03/21/2024.The EPS is expected to grow by 48.12% this year.

SELLAS Life Sciences Group Inc (SLS) Top Institutional Holders

The shares outstanding are 32.06M, and float is at 31.98M with Short Float at 14.42%.

SELLAS Life Sciences Group Inc (SLS) Insider Activity

A total of 0 insider transactions have happened at SELLAS Life Sciences Group Inc (SLS) in the last six months, with sales accounting for 0 and purchases happening 0 times.